rubella
RUBELLA
Rubella, also known as German measles or 3-day measles, is a mild often exanthematous disease of infants and children that is severe and associated with complications in adults. It is self-limiting disease associated with a characteristic maculopapular rash.
It is caused by a single-stranded RNA virus classified as a togavirus, genus Rubivirus.
Transmission is through airborne or droplets shed from respiratory secretions.
Highly communicable at the onset of the rash, however viral shedding may also occur 5-7 days before, to 5-7 days or more following appearance of the rash.
The incubation period is 14-21 days.

Rubella Management

Prevention

Rubella vaccine is available as a single-antigen preparation or combined w/ other vaccines [eg mumps & rubella (MMR), or also w/ varicella (MMRV)]

  • MMRV is approved for use in healthy children ≥1-12 yrs of age
  • Routine vaccination against rubella is recommended for all children ≥12 mth; second dose should be routinely given at 4-6 yrs of age
  • Children ≤12 yr w/o previous immunization should be given at least 1 dose of MMR or MMRV
  • May be effective, theoretically, as post-exposure prophylaxis if given w/in 3 days of exposure
  • Single antigen is not routinely recommended

Prevention for Exposed Pregnant Women

  • Counseling regarding the risks & benefits of termination of pregnancy should be off ered to susceptible pregnant women exposed to rubella

Post-exposure Prophylaxis

  • Immunoglobulin may be given if termination of pregnancy is not an option based on maternal predilection
    • May reduce the risk of clinical infection but may not give an assurance of prevention of fetal infection
    • Dose of 0.55 mL/kg IM may be given
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 2 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.